Advertisement
|
|
|
|
|
Free Trial
Description: Wayne Shields is ARHP CEO/President. With a Lead411 subscription, ARHP email addresses ( @arhp.org ) of the executives are viewable. Other information includes Wayne Shields email, phone, and extension.
Be sure to check our Linkedin tab on the company page. Typical management titles include VP, Chief, Vice President, Director, manager, & more. Similar names to Shields can be found at Executive Directory - Shields.
|
Add Wayne Shields Information
Site Reference: http://www.arhp.org/publications-and-resources/contraception-journal/december-2008
Wayne Shields and Emily Galpern Content Block : Join Now to Subscribe Join Now to Subscribe ARHP members receive the Contraception Journal as one of the many benefits of membership, saving significantly off of the $354 non-member subscription rate. Join Now > The rapid advancement of reproductive science, fueled by such major events as the completion of the human genome project in April 2003 1 and marked by technologies such as preimplantation genetic diagnosis (PGD), has brought a sea of change in health care that has already begun to impact our lives. And, for all of the benefits and risks involved, reproductive genetics will continue to influence health care in significant ways over the next decade. The swift growth in these new technologies calls for reproductive health providers to thoroughly educate themselves, to better understand implications for health care practice, to advocate for clear safety measures to ensure the health Association of Reproductive Health Professionals Washington, DC Emily Galpern Project on Reproductive Health, Rights and Justice, Generations Ahead Oakland, CA References National Human Genome Research Institute. All About The Human Genome Project (HGP). http://www.genome.gov/10001772 . Accessed August 28, 2008. GeneticHealth.com. Genetics and the Future of Medicine. http://www.genetichealth.com/G101_Genetics_and_the_Future_of_Medicine.shtml . Accessed August 28, 2008. Roberts D. Race and the Biotech Agenda. http://www.geneticsandsociety.org/article.php?id=1996 . Accessed August 28, 2008. http://www.news-medical.net/?id=7317 ; Accessed August 28, 2008. Reproductive Health Technologies Project. Ovarian Stimulation and Egg Retrieval: Overview and Issues to Consider. http://www.rhtp.org/fertility/assisted/documents/OvarianStimulationandEggRetrieval-Issues.pdf . Accessed August 28, 2008. Bhattacharya S, Harrild K, Mollison J, et al. Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomized controlled trial. . BMJ . 2008; 337 : a716 . I ntegrMed, Fertility Network. Making Sense of IVF Success Rates. http://www.integramed.com/inmdweb/content/cons/conceptions/successrates.jsp . Accessed August 28, 2008. [ back to top ] Used with permission from Elsevier, Inc.
|
|
| Copyright 2010 Lead411 | Santa Barbara, CA |
|
|
|
|
Advertisement
|
